151 related articles for article (PubMed ID: 1374726)
1. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection.
Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE
Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726
[TBL] [Abstract][Full Text] [Related]
2. The 2-5A system and HIV infection.
Schröder HC; Kelve M; Müller WE
Prog Mol Subcell Biol; 1994; 14():176-97. PubMed ID: 7914804
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
4. 2-5A-antisense chimeras: inhibitors of respiratory syncytial virus infection.
Torrence PF
Curr Opin Mol Ther; 1999 Jun; 1(3):307-15. PubMed ID: 11713795
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).
Homan JW; Steele AD; Martinand-Mari C; Rogers TJ; Henderson EE; Charubala R; Pfleiderer W; Reichenbach NL; Suhadolnik RJ
J Acquir Immune Defic Syndr; 2002 May; 30(1):9-20. PubMed ID: 12048358
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the antiretroviral effect of dsRNA.
Müller WE; Ushijima H; Schröder HC
Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807
[No Abstract] [Full Text] [Related]
7. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
[TBL] [Abstract][Full Text] [Related]
8. Cordycepin analogues of 2',5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase.
Müller WE; Weiler BE; Charubala R; Pfleiderer W; Leserman L; Sobol RW; Suhadolnik RJ; Schröder HC
Biochemistry; 1991 Feb; 30(8):2027-33. PubMed ID: 1705437
[TBL] [Abstract][Full Text] [Related]
9. Evidence for age-dependent impairment of antiviral 2',5'-oligoadenylate synthetase/ribonuclease L-system in tissues of rat.
Pfeifer K; Ushijima H; Lorenz B; Müller WE; Schröder HC
Mech Ageing Dev; 1993 Feb; 67(1-2):101-14. PubMed ID: 8469023
[TBL] [Abstract][Full Text] [Related]
10. Photolabeling of the enzymes of the 2-5A synthetase/RNase L/p68 kinase antiviral systems with azido probes.
Suhadolnik RJ
Prog Mol Subcell Biol; 1994; 14():260-75. PubMed ID: 7520331
[No Abstract] [Full Text] [Related]
11. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).
Dimitrova DI; Reichenbach NL; Yang X; Pfleiderer W; Charubala R; Gaughan JP; Suh B; Henderson EE; Suhadolnik RJ; Rogers TJ
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):123-34. PubMed ID: 17263642
[TBL] [Abstract][Full Text] [Related]
13. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.
Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B
Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186
[TBL] [Abstract][Full Text] [Related]
14. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene.
Schröder HC; Ugarkovic D; Merz H; Kuchino Y; Okamoto T; Müller WE
FASEB J; 1990 Oct; 4(13):3124-30. PubMed ID: 1698680
[TBL] [Abstract][Full Text] [Related]
15. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.
Suhadolnik RJ; Reichenbach NL; Hitzges P; Sobol RW; Peterson DL; Henry B; Ablashi DV; Müller WE; Schröder HC; Carter WA
Clin Infect Dis; 1994 Jan; 18 Suppl 1():S96-104. PubMed ID: 8148461
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
Carey CM; Govande AA; Cooper JM; Hartley MK; Kranzusch PJ; Elde NC
Cell Host Microbe; 2019 Feb; 25(2):336-343.e4. PubMed ID: 30713099
[TBL] [Abstract][Full Text] [Related]
18. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
19. 2',5'-Oligoadenylate synthetase-uninducible alpha/beta-interferon-resistant Friend cells develop an antiviral state when permeabilized with lysolecithin and treated with 2',5'-oligoadenylate oligomers.
Federico M; Romeo G; Affabris E; Coccia EM; Rossi GB
J Interferon Res; 1986 Jun; 6(3):233-40. PubMed ID: 3462265
[TBL] [Abstract][Full Text] [Related]
20. 2-5A and virus infection.
Fujii N
Prog Mol Subcell Biol; 1994; 14():150-75. PubMed ID: 8061884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
